Faris Tamimi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Endometrial Cancer

Cross Sectional

Top Venues

Breast cancer (Dove Medical Press)

Journal for immunotherapy of cancer

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Hikmat Abdel-Razeq, Hira Bani Hani, Baha' Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study. Cancers 16 (14) (2024)
Hikmat Abdel-Razeq, Hira Bani Hani, Baha' Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study. Cancers 16 (14) (2024)
Hikmat Abdel-Razeq, Hira Bani Hani, Baha' Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study. Cancers 16 (14) (2024)
Baha' Sharaf, Hala Abu-Fares, Faris Tamimi, Suhaib Al-Sawajneh, Osama Salama, Rand Daoud, Abdulrahman A Alhajahjeh, Sawsan Al-Lababidi, Hikmat Abdel-Razeq
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib. Breast cancer (Dove Medical Press) 15 (2023)
Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Mais Alkyam, Baha' Sharaf, Shatha Elemian, Faris Tamimi, Fawzi Abuhijla, Sarah Edaily, Osama Salama, Hazem Abdulelah, Rand Daoud, Mohammad Abubaker, Areej Al-Atary
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Breast cancer (Dove Medical Press) 15 (2023)
Abhenil Mittal, Consolacion Molto Valiente, Faris Tamimi, Ilana Schlam, Sarah Sammons, Sara M Tolaney, Paolo Tarantino
Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer. Cancers 15 (7) (2023)
Laith Al-Showbaki, Brooke Wilson, Faris Tamimi, Consolacion Molto, Abhenil Mittal, David W Cescon, Eitan Amir
Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review. Journal for immunotherapy of cancer 11 (2) (2023)
Laith Al-Showbaki, Brooke Wilson, Faris Tamimi, Consolacion Molto, Abhenil Mittal, David W Cescon, Eitan Amir
Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review. Journal for immunotherapy of cancer 11 (2) (2023)
Hikmat Abdel-Razeq, Faris Tamimi, Mohammed J Al-Jaghbeer, Baha' Sharaf, Rashid Abdel-Razeq, Jafar Bani Issa, Hala Abu-Jaish, Osama Salama
Survival Outcomes after Placement of Inferior Vena Cava Filters in Cancer Patients: Insights from a Comprehensive Cancer Center's Experience. Journal of clinical medicine 12 (23) (2023)
Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Mais Alkyam, Baha' Sharaf, Shatha Elemian, Faris Tamimi, Fawzi Abuhijla, Sarah Edaily, Osama Salama, Hazem Abdulelah, Rand Daoud, Mohammad Abubaker, Areej Al-Atary
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Breast cancer (Dove Medical Press) 15 (2023)
Laith Al-Showbaki, Brooke Wilson, Faris Tamimi, Consolacion Molto, Abhenil Mittal, David W Cescon, Eitan Amir
Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review. Journal for immunotherapy of cancer 11 (2) (2023)
Samer Salah, Ramiz Abu-Hijlih, Fawzi Abuhijla, Faris Tamimi, Abdallah Al-Tell, Mohammed Shahait
Pretreatment neutrophil-to-lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration-sensitive prostate cancer. Cancer reports (Hoboken, N.J.) 4 (5) (2021)
Hikmat Abdel-Razeq, Faris Tamimi, Lama Abujamous, Sara Edaily, Mahmoud Abu Nasser, Rayan Bater, Osama Salama
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives. Cancer management and research 13 (2021)